Literature DB >> 10714670

Levodopa toxicity in Parkinson disease: reality or myth? Reality--practice patterns should change.

L M Shulman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10714670     DOI： 10.1001/archneur.57.3.406

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  4 in total

1.  Beneficial antioxidant properties of betaine against oxidative stress mediated by levodopa/benserazide in the brain of rats.

Authors:  Masoud Alirezaei; Zeynab Khoshdel; Omid Dezfoulian; Marzyeh Rashidipour; Vahideh Taghadosi
Journal:  J Physiol Sci       Date:  2015-02-11       Impact factor: 2.781

2.  Parkinson's Disease: Initial Treatment with Levodopa or Dopamine Agonists.

Authors:  Stewart A. Factor
Journal:  Curr Treat Options Neurol       Date:  2001-11       Impact factor: 3.598

3.  Protective effects of Althaea officinalis L. extract in 6-hydroxydopamine-induced hemi-Parkinsonism model: behavioral, biochemical and histochemical evidence.

Authors:  Maryam Rezaei; Masoud Alirezaei
Journal:  J Physiol Sci       Date:  2014-01-25       Impact factor: 2.781

Review 4.  Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease.

Authors:  Sushruta Koppula; Hemant Kumar; Sandeep Vasant More; Byung Wook Kim; In Su Kim; Dong-Kug Choi
Journal:  Int J Mol Sci       Date:  2012-08-23       Impact factor: 6.208
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.